Insecticides India
- P/E
- 12.89
Key Fundamentals
MicrocapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 15.80%
- Debt to Equity
- 0.13
- EPS (TTM)
- ₹43.02
- Book Value
- ₹419.42
- Market Cap
- —
- P/E (TTM)
- 12.89
- P/B
- 1.32
- ROE
- 12.00%
- Dividend Yield
- 0.36%
- EBITDA
- ₹239 Cr
- 52W High
- ₹775.00
- 52W Low
- ₹500.00
- Day Range
- ₹542.05 – ₹558.95
- Volume
- 11,620
Peer Comparison
Commodities › Chemicals › Pesticides & Agrochemicals
| ₹529.00 | 22.09 | ₹43,728 Cr | 1.28 | 1.16% | 5.64% | 10.10% | ₹52,804 Cr | ₹2,323 Cr | |
| ₹2,187.00 | 28.48 | ₹33,248 Cr | 2.95 | 0.69% | 11.20% | 15.00% | ₹6,516 Cr | ₹1,164 Cr | |
| ₹328.10 | 28.24 | ₹15,980 Cr | 4.43 | 0.41% | 17.60% | 23.50% | ₹3,192 Cr | ₹581 Cr | |
| ₹3,249.90 | 19.95 | ₹14,602 Cr | 4.92 | 4.57% | 23.70% | 29.10% | ₹5,595 Cr | ₹733 Cr | |
| ₹677.95 | 9.77 | ₹6,015 Cr | 1.88 | 2.23% | 23.20% | 30.20% | ₹5,357 Cr | ₹626 Cr | |
| ₹942.75 | 15.83 | ₹4,217 Cr | 2.50 | 0.21% | 18.50% | 23.80% | ₹1,953 Cr | ₹268 Cr | |
| ₹189.67 | 17.23 | ₹3,734 Cr | 1.68 | 1.58% | 10.20% | 14.10% | ₹2,962 Cr | ₹214 Cr | |
| Insecticides (this company) | ₹554.70 | 12.89 | ₹1,601 Cr | 1.32 | 0.36% | 12.00% | 15.80% | ₹2,060 Cr | ₹125 Cr |
| Median 8 companies | ₹616.33 | 18.59 | ₹10,309 Cr | 2.19 | 0.93% | 14.80% | 19.65% | ₹4,275 Cr | ₹604 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 50
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 57
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 29
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 58
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 18
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 55
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
2- The company has delivered a poor sales growth of 8.55% over past five years.
- Company has a low return on equity of 12.0% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 6 | 5 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 48.68
- Neutral
- MACD (12,26,9)
- −14.54
- Bullish
- SMA (50)
- 579.90
- Bearish
- SMA (200)
- 634.81
- Bearish
As of
Analyst Rating
1 of 1 analyst rates Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +8.98% |
|---|---|
| 5Y | +8.55% |
| 3Y | +5.92% |
| 1Y | +7.00% |
| TTM | +1.28% |
Net profit
| 10Y | +13.26% |
|---|---|
| 5Y | +8.14% |
| 3Y | +30.18% |
| 1Y | −2.11% |
| TTM | −16.67% |
Operating cash flow
| 10Y | +1.52% |
|---|---|
| 5Y | −8.39% |
| 3Y | Turned positive |
| 1Y | +7.53% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +0.46 pp |
|---|---|
| 5Y | −0.16 pp |
| 3Y | +3.84 pp |
| 1Y | −0.44 pp |
| TTM | −1.36 pp |
Revenue by year
| Mar 2017 | ₹994 Cr |
|---|---|
| Mar 2018 | ₹1,073 Cr |
| Mar 2019 | ₹1,194 Cr |
| Mar 2020 | ₹1,363 Cr |
| Mar 2021 | ₹1,420 Cr |
| Mar 2022 | ₹1,504 Cr |
| Mar 2023 | ₹1,801 Cr |
| Mar 2024 | ₹1,966 Cr |
| Mar 2025 | ₹2,000 Cr |
| Mar 2026 | ₹2,140 Cr |
Net profit by year
| Mar 2017 | ₹60.00 Cr |
|---|---|
| Mar 2018 | ₹84.00 Cr |
| Mar 2019 | ₹123 Cr |
| Mar 2020 | ₹87.00 Cr |
| Mar 2021 | ₹94.00 Cr |
| Mar 2022 | ₹107 Cr |
| Mar 2023 | ₹63.00 Cr |
| Mar 2024 | ₹102 Cr |
| Mar 2025 | ₹142 Cr |
| Mar 2026 | ₹139 Cr |
Analyst Forecasts
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 640 | 696 | 358 | 272 | 657 | 627 | 358 | 359 | 691 | 638 | 385 | 426 | 612 |
| Expenses | 594 | 614 | 332 | 264 | 585 | 538 | 327 | 330 | 607 | 548 | 358 | 401 | 544 |
| Operating Profit | 46 | 82 | 26 | 9 | 72 | 90 | 31 | 28 | 85 | 89 | 27 | 25 | 68 |
| OPM % | 7% | 12% | 7% | 3.3% | 11% | 14% | 9% | 8% | 12% | 14% | 7% | 6% | 11% |
| Other Income | 4 | 0 | 1 | 5 | 3 | 2 | 0.16 | 3 | 4 | 3 | 1 | 5 | 5.34 |
| Interest | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 | 5 | 4 | 5 |
| Depreciation | 7 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 | 9 | 9 | 10 |
| PBT | 39.49 | 72 | 17 | 4 | 65.25 | 82 | 22 | 22 | 77 | 79 | 14 | 16 | 59 |
| Tax % | 26% | 26% | 28% | −106% | 25% | 25% | 22% | 37% | 25% | 25% | 27% | 27% | 25% |
| Net Profit | 29 | 53 | 12 | 8 | 49 | 61 | 17 | 14 | 58 | 59 | 10 | 12 | 44 |
| EPS (₹) | 9.85 | 17.96 | 4.16 | 2.62 | 16.68 | 21.13 | 5.97 | 4.77 | 19.97 | 20.31 | 3.61 | 4.02 | 15.08 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 893 | 906 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,000 | 2,140 | 2,060 |
| Expenses | 782 | 814 | 882 | 925 | 1,006 | 1,207 | 1,268 | 1,333 | 1,679 | 1,804 | 1,779 | 1,913 | 1,851 |
| Operating Profit | 111 | 92 | 112 | 148 | 188 | 156 | 153 | 171 | 122 | 162 | 221 | 227 | 210 |
| OPM % | 12% | 10% | 11% | 14% | 16% | 11% | 11% | 11% | 7% | 8% | 11% | 11% | 10% |
| Other Income | 0 | 0 | 7 | 3 | 1 | 3 | −2 | 3 | 1 | 10 | 8 | 12 | 14 |
| Interest | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 17 | 18 |
| Depreciation | 15 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 36 | 38 |
| PBT | 64 | 50 | 82 | 118 | 153 | 111 | 120 | 141 | 84 | 132 | 193 | 187 | 168 |
| Tax % | 14% | 21% | 27% | 29% | 20% | 22% | 21% | 24% | 25% | 23% | 26% | 25% | — |
| Net Profit | 55 | 40 | 60 | 84 | 123 | 87 | 94 | 107 | 63 | 102 | 142 | 139 | 125 |
| EPS (₹) | 19.24 | 12.77 | 19.26 | 27.19 | 39.62 | 28.04 | 30.29 | 36.29 | 21.36 | 34.49 | 48.81 | 47.91 | 43.02 |
| Div. Payout % | 0% | 10% | 7% | 5% | 3% | 10% | 4% | 6% | 14% | 9% | 4% | 4% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 |
| Reserves | 278 | 388 | 444 | 527 | 641 | 711 | 800 | 850 | 889 | 982 | 1,056 | 1,191 |
| Borrowings | 322 | 206 | 237 | 114 | 305 | 191 | 100 | 54 | 163 | 87 | 105 | 157 |
| Other Liabilities | 308 | 321 | 277 | 338 | 388 | 372 | 505 | 473 | 615 | 620 | 709 | 623 |
| Total Liabilities | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 |
| Fixed Assets | 210 | 198 | 185 | 232 | 240 | 239 | 239 | 253 | 263 | 286 | 282 | 370 |
| CWIP | 38 | 51 | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 142 | 161 | 130 |
| Investments | 3 | 3 | 11 | 17 | 12 | 12 | 14 | 16 | 17 | 23 | 29 | 29 |
| Other Assets | 670 | 684 | 725 | 735 | 1,084 | 1,004 | 1,115 | 1,037 | 1,294 | 1,268 | 1,426 | 1,472 |
| Total Assets | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | −6 | 86 | 4 | 182 | −133 | 242 | 155 | 135 | −11 | 187 | 93 | 100 |
| Investing | −34 | −19 | −14 | −26 | −49 | −24 | −113 | 9 | −86 | −46 | −38 | −86 |
| Financing | 36 | −64 | 9 | −143 | 172 | −159 | −104 | −115 | 80 | −98 | −61 | 18 |
| Net Cash Flow | −4 | 4 | 0 | 13 | −11 | 59 | −61 | 30 | −17 | 42 | −5 | 31 |
| Free Cash Flow | −40 | 67 | −10 | 154 | −171 | 213 | 108 | 68 | −97 | 143 | 59 | 8 |
| CFO/EBITDA | 1 | 108 | 19 | 140 | −54 | 175 | 120 | 103 | 16 | 124 | 61 | 69 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68 | 84 | 78 | 80 | 75 | 86 | 65 | 70 | 60 | 55 | 70 | 83 |
| Inventory Days | 220 | 190 | 232 | 214 | 355 | 202 | 248 | 228 | 247 | 221 | 268 | 215 |
| Days Payable | 118 | 114 | 108 | 128 | 141 | 96 | 136 | 117 | 128 | 115 | 154 | 121 |
| Cash Conversion Cycle | 170 | 159 | 201 | 166 | 289 | 192 | 177 | 181 | 178 | 161 | 185 | 177 |
| Working Capital Days | 40 | 75 | 80 | 93 | 116 | 98 | 108 | 111 | 92 | 97 | 106 | 105 |
| ROCE % | — | 12% | 16% | 20% | 21% | 14% | 15% | 16% | 10% | 13% | 17% | 16% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Insecticides insights
63 extracted metrics across FY11–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript Recording
- Q4 FY26 concall · Jun 2026Transcript PPT
- Q4 FY26 concall · May 2026PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT
- 28 May 2026
- 25 Sep 2026
- 9 Jul 2025
- 17 Jun 2025
- 19 Mar 2024
- 30 Dec 2022
- General announcements 7 Oct 2026
- General announcements 7 Oct 2026
Frequently Asked Questions about Insecticides India
What does Insecticides India Ltd do?
Where is Insecticides India Ltd (INSECTICID) listed?
Which sector does Insecticides India Ltd belong to?
What is the PE ratio of Insecticides India Ltd?
What is the 52-week high and low of Insecticides India Ltd?
Does Insecticides India Ltd pay dividends?
What is the Return on Equity (ROE) of Insecticides India Ltd?
Company Information
Insecticides India is into manufacturing of agrochemicals (technicals and formulations) and biological and household products. They cater to Indian market where they directly sell to the end consumer and also sell technicals and formulations to the companies who are in the business of formulation. They also export to 30 countries with more than 100 customers through registrations. IIL has more than 75 registrations so far.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INSECTICID.md for Insecticides India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.